Get 20% lifetime commission for referring investors to digrin.com
here.
Cumberland Pharmaceuticals Inc. (CPIX) Financials
CPIX Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2026 | 62.9 million | 45.8 million |
| March 31, 2026 | 71.0 million | 49.7 million |
| Dec. 31, 2025 | 76.8 million | 52.3 million |
| Sept. 30, 2025 | 65.9 million | 40.1 million |
CPIX Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2026 | 134542 | 77866 |
| March 31, 2026 | 387025 | 106842 |
| Dec. 31, 2025 | -40817 | 172160 |
| Sept. 30, 2025 | 154943 | 81262 |
CPIX Net Income
No data available :(
CPIX Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2026 | 3.9 million | - | 4.7 million |
| March 31, 2026 | 11.0 million | 5.2 million | 4.3 million |
| Dec. 31, 2025 | 11.4 million | 5.2 million | 4.9 million |
| Sept. 30, 2025 | 15.2 million | 5.2 million | 4.6 million |
CPIX Shares Outstanding
CPIX Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2026 | 38278 | 772162 | 2.5 million | 5.1 million |
| March 31, 2026 | 5 | 1.5 million | 7.6 million | 5.1 million |
| Dec. 31, 2025 | 43841 | 1.5 million | 10.2 million | 6.2 million |
| Sept. 30, 2025 | 32237 | 1.3 million | 7.0 million | 4.4 million |
CPIX Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2026 | 166458 | 37404 |
| March 31, 2026 | 9.1 million | 1.9 million |
| Dec. 31, 2025 | 13.7 million | 2.2 million |
| Sept. 30, 2025 | 8.3 million | 988760 |
CPIX Revenue by Segment
Graph available only for paid members. Upgrade to see it.
CPIX
Price: $7.18
52 week price:
Dividend Yield: 21.77%
Earnings Per Share: -0.62 USD
Exchange: NMS
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Country: United States
Volume: 32200
Ebitda: -84615Market Capitalization: 103.2 million